Buprenorphine Program is a Substance Abuse Clinics (Outpatient) business in New York City, NY.
| Company Name: | Buprenorphine Program |
| Company Classification: | Substance Abuse Clinics (Outpatient) |
| Company Location: | 710 West 168th St Floor 12, New York City, NY 10032 |
| Telephone Number: | (212) 342-1496 |
| Company Representative: | Herbert Kleber |
| NAICS Number: | 621498 |
| SIC Number: | 8093 |
| Market Factor: | B2C (Business to Consumer) |
| Begining Year: | 2007 |
| Employee Amount: | 1 to 4 |
| Location Category: | Single Location |
| Annual Earning (USD): | $100.000 to $499.999 |
| Share This Business: |
Buprenorphine Program is a company that has been operational since 2007, offering products or services in the industry of Substance Abuse Clinics (Outpatient). For additional details of the nature of this business, it is registered under with the SIC code 8093 and under the NAICS code 621498 ().
Buprenorphine Program now supports a growing employee population of 1 to 4 and the business makes an estimated annual revenue of $100.000 to $499.999. The company can be reached for inquiries about B2C market variables and other concerns by contacting Herbert Kleber by phone (212) 342-1496.
For added convenience and more information, Buprenorphine Program also has a website at , and can be accessed and followed through the social media outlets Twitter and Facebook . Visit Buprenorphine Program’s physical single location at 710 West 168th St Floor 12, New York, New York or locate it via the coordinates 40.842298,-73.942916.